1303590-18-2

Basic information

• Product Name: (4S,5S)-3-tert-Butyl 4-Methyl 2,2,5-triMethyloxazolidine-3,4-dicarboxylate
• Synonyms: (4S,5S)-3-tert-Butyl 4-Methyl 2,2,5-triMethyloxazolidine-3,4-dicarboxylate
• CAS NO: 1303590-18-2
• Molecular Formula: C13H23NO5
• Molecular Weight: 273.32542
• Mol File: 1303590-18-2.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4S,5S)-3-tert-Butyl 4-Methyl 2,2,5-triMethyloxazolidine-3,4-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (4S,5S)-3-tert-Butyl 4-Methyl 2,2,5-triMethyloxazolidine-3,4-dicarboxylate(1303590-18-2)
• EPA Substance Registry System: (4S,5S)-3-tert-Butyl 4-Methyl 2,2,5-triMethyloxazolidine-3,4-dicarboxylate(1303590-18-2)

Safety Data

• Hazardous Substances Data: 1303590-18-2(Hazardous Substances Data)

Upstream product

• 72-19-5 L-threonine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 77-76-9 2,2-dimethoxy-propane 
• 96099-84-2 (2R,3S)-methyl 2-<(tert-butoxycarbonyl)amino>-3-hydroxybutanoate 
• 118525-51-2 (2R,3R)-methyl 2-amino-3-hydroxybutanoate 
• 60538-19-4 methyl (2R,3R)-2-[[(tert-butoxy)carbonyl]amino]-3-hydroxybutanoate 
• 113525-91-0 (2S,3S)-methyl 2-[(tert-butoxycarbonyl)amino]-3-hydroxybutanoate 
• 2592-18-9 N-(t-Butyloxycarbonyl)-L-threonine 
• 116-11-0 2-Methoxypropene 
• 60538-19-4 N-(tert-butoxycarbonyl)-l-threonine methyl ester 

Downstream Products

• 1246391-46-7 (4S,5R)-tert-butyl 4-((5-chloro-2-fluoro-4-(5-(2-(isopropylamino)-6-methylpyridin-4-yl)-1,3,4-thiadiazol-2-yl)phenoxy)methyl)-2,2,5-trimethyloxazolidine-3-carboxylate 
• 108149-62-8 (4S,5R)-3-(tert-Butoxycarbonyl)-4-formyl-2,2,5-trimethyloxazolidine 

Relevant articles and documents

N-1 BRANCHED ALKYL ETHER SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS

Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.

OXADIAZOLE MODULATORS OF S1P METHODS OF MAKING AND USING

The invention is directed to Compounds of Formula (I): wherein each variable is defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance for treating graft versus host disease and autoimmune diseases.

CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of Formula (I-A), including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein Ra to Rd, and R1 to R8 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.